Patents by Inventor Peter Cohen

Peter Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTENNA DESIGN USING ARTIFICIAL INTELLIGENCE
    Publication number: 20240135081
    Abstract: The disclosed computer-implemented method may include accessing various antenna elements and identifying parameters for an antenna that is to be formed using the accessed antenna elements. The method may also include assembling the antenna elements, using an artificial intelligence (AI) instance, into an assembled antenna that at least partially complies with the identified parameters. Various other methods, systems, and computer-readable media are also disclosed.
    Type: Application
    Filed: October 18, 2022
    Publication date: April 25, 2024
    Inventors: Weiping Dou, Jiang Zhu, Yuandong Tian, Andrew Cohen, Ulf Jan-Ove Mattsson, Peter Eli Renner, Yang Zhong, Xiaomeng Yang, Geng Ye
  • Wireless communication technology, apparatuses, and methods
    Patent number: 11955732
    Abstract: Millimeter wave (mmWave) technology, apparatuses, and methods that relate to transceivers, receivers, and antenna structures for wireless communications are described. The various aspects include co-located millimeter wave (mmWave) and near-field communication (NFC) antennas, scalable phased array radio transceiver architecture (SPARTA), phased array distributed communication system with MIMO support and phase noise synchronization over a single coax cable, communicating RF signals over cable (RFoC) in a distributed phased array communication system, clock noise leakage reduction, IF-to-RF companion chip for backwards and forwards compatibility and modularity, on-package matching networks, 5G scalable receiver (Rx) architecture, among others.
    Type: Grant
    Filed: December 27, 2022
    Date of Patent: April 9, 2024
    Assignee: Intel Corporation
    Inventors: Erkan Alpman, Arnaud Lucres Amadjikpe, Omer Asaf, Kameran Azadet, Rotem Banin, Miroslav Baryakh, Anat Bazov, Stefano Brenna, Bryan K. Casper, Anandaroop Chakrabarti, Gregory Chance, Debabani Choudhury, Emanuel Cohen, Claudio Da Silva, Sidharth Dalmia, Saeid Daneshgar Asl, Kaushik Dasgupta, Kunal Datta, Brandon Davis, Ofir Degani, Amr M. Fahim, Amit Freiman, Michael Genossar, Eran Gerson, Eyal Goldberger, Eshel Gordon, Meir Gordon, Josef Hagn, Shinwon Kang, Te Yu Kao, Noam Kogan, Mikko S. Komulainen, Igal Yehuda Kushnir, Saku Lahti, Mikko M. Lampinen, Naftali Landsberg, Wook Bong Lee, Run Levinger, Albert Molina, Resti Montoya Moreno, Tawfiq Musah, Nathan G. Narevsky, Hosein Nikopour, Oner Orhan, Georgios Palaskas, Stefano Pellerano, Ron Pongratz, Ashoke Ravi, Shmuel Ravid, Peter Andrew Sagazio, Eren Sasoglu, Lior Shakedd, Gadi Shor, Baljit Singh, Menashe Soffer, Ra'anan Sover, Shilpa Talwar, Nebil Tanzi, Moshe Teplitsky, Chintan S. Thakkar, Jayprakash Thakur, Avi Tsarfati, Yossi Tsfati, Marian Verhelst, Nir Weisman, Shuhei Yamada, Ana M. Yepes, Duncan Kitchin
  • SYSTEM TO CONVERT CELLULOSIC MATERIALS INTO SUGAR AND METHOD OF USING THE SAME
    Publication number: 20230364577
    Abstract: A device for converting cellulose to sugar has a reaction chamber with a plurality of control components, and a control assembly. The control assembly is operatively connected to the reaction chamber, a drive assembly and control components to transmit and receive interoperability signals. The device has an inlet hopper with a detector, a crusher, an outlet hopper, a sensor assembly, a steam inlet, and a carbon dioxide inlet. The inlet hopper is configured to receive and analyze proportion data of matters in a feedstock and catalyst mixture via the detector. The crusher receives and grinds the mixture from the inlet hopper to induce chemical reaction for producing sugar. The outlet hopper is configured to determine a proportion data of matter in the grinded mixture. The control assembly is configured to determine adjustments need to be performed on the components and drive assembly to optimize the sugar production.
    Type: Application
    Filed: July 25, 2023
    Publication date: November 16, 2023
    Inventors: Benjamin Slager, Peter Cohen, Eric Libra
  • METHODS AND MATERIALS FOR EXPANDING ANTIGEN-SPECIFIC T CELLS IN CULTURE
    Publication number: 20230357718
    Abstract: This document provides methods and materials for expanding antigen-specific T cells (e.g., antigen-specific CD4+ T cells and/or antigen-specific CD8+ T cells) in culture. For example, methods and materials for performing a polyclonal stimulation step for a particular duration (e.g., from about 1 hour to about 48 hours) to increase the expansion of T cells having a desired antigen specificity are provided.
    Type: Application
    Filed: July 13, 2023
    Publication date: November 9, 2023
    Applicants: Mayo Foundation for Medical Education and Research, University of Washington
    Inventors: Peter A. Cohen, JR., Sandra J. Gendler, Latha B. Pathangey, Dustin B. McCurry, Jessica E. Gorman, Mary L. Disis
  • Methods and materials for expanding antigen-specific T cells in culture
    Patent number: 11739296
    Abstract: This document provides methods and materials for expanding antigen-specific T cells (e.g., antigen-specific CD4+ T cells and/or antigen-specific CD8+ T cells) in culture. For example, methods and materials for performing a polyclonal stimulation step for a particular duration (e.g., from about 1 hour to about 48 hours) to increase the expansion of T cells having a desired antigen specificity are provided.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: August 29, 2023
    Assignees: Mayo Foundation for Medical Education and Research, University of Washington
    Inventors: Peter A. Cohen, Sandra J. Gendler, Latha B. Pathangey, Dustin B. McCurry, Jessica E. Gorman, Mary L. Disis
  • METHODS AND VACCINES FOR INDUCING IMMUNE RESPONSES TO MULTIPLE DIFFERENT MHC MOLECULES
    Publication number: 20230098624
    Abstract: This document provides methods and materials relating to isolated polypeptides, polypeptide preparations, vaccine preparations (e.g., anti-cancer vaccine preparations), and methods for vaccinating mammals. For example, polypeptides (e.g., CMV, MUC1, HER2, Mesothelin (MESO), TRAG-3, or CALR polypeptides) having the ability to be processed into different polypeptides such that the processed polypeptides as a group are capable of being presented by different MHC molecules present in a particular mammalian population are provided.
    Type: Application
    Filed: August 24, 2022
    Publication date: March 30, 2023
    Inventors: Dustin B. McCurry, Peter A. Cohen, Latha B. Pathangey, Sandra J. Gendler, Mary L. Disis
  • SYSTEM TO CONVERT CELLULOSIC MATERIALS INTO SUGAR AND METHOD OF USING THE SAME
    Publication number: 20230026152
    Abstract: A device for converting cellulose to sugar has a reaction chamber with a plurality of control components, and a control assembly. The control assembly is operatively connected to the reaction chamber, a drive assembly and control components to transmit and receive interoperability signals. The device has an inlet hopper with a detector, a crusher, an outlet hopper, a sensor assembly, a steam inlet, and a carbon dioxide inlet. The inlet hopper is configured to receive and analyze proportion data of matters in a feedstock and catalyst mixture via the detector. The crusher receives and grinds the mixture from the inlet hopper to induce chemical reaction for producing sugar. The outlet hopper is configured to determine a proportion data of matter in the grinded mixture. The control assembly is configured to determine adjustments need to be performed on the components and drive assembly to optimize the sugar production.
    Type: Application
    Filed: September 29, 2022
    Publication date: January 26, 2023
    Inventors: Benjamin Slager, Peter Cohen
  • System to convert cellulosic materials into sugar and method of using the same
    Patent number: 11484858
    Abstract: A device for converting cellulose to sugar has a reaction chamber with a plurality of control components, and a control assembly. The control assembly is operatively connected to the reaction chamber, a drive assembly and control components to transmit and receive interoperability signals. The device has an inlet hopper with a detector, a crusher, an outlet hopper, a sensor assembly, a steam inlet, and a carbon dioxide inlet. The inlet hopper is configured to receive and analyze proportion data of matters in a feedstock and catalyst mixture via the detector. The crusher receives and grinds the mixture from the inlet hopper to induce chemical reaction for producing sugar. The outlet hopper is configured to determine a proportion data of matter in the grinded mixture. The control assembly is configured to determine adjustments need to be performed on the components and drive assembly to optimize the sugar production.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: November 1, 2022
    Assignee: Alliance BioEnergy Plus Inc.
    Inventors: Benjamin Slager, Peter Cohen
  • Methods and vaccines for inducing immune responses to multiple different MHC molecules
    Patent number: 11464839
    Abstract: This document provides methods and materials relating to isolated polypeptides, polypeptide preparations, vaccine preparations (e.g., anti-cancer vaccine preparations), and methods for vaccinating mammals. For example, polypeptides (e.g., CMV, MUC1, HER2, Mesothelin (MESO), TRAG-3, or CALR polypeptides) having the ability to be processed into different polypeptides such that the processed polypeptides as a group are capable of being presented by different MHC molecules present in a particular mammalian population are provided.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: October 11, 2022
    Assignees: Mayo Foundation for Medical Education and Research, University of Washington
    Inventors: Dustin B. McCurry, Peter A. Cohen, Latha B. Pathangey, Sandra J. Gendler, Mary L. Disis
  • SYSTEM TO CONVERT CELLULOSIC MATERIALS INTO SUGAR AND METHOD OF USING THE SAME
    Publication number: 20210213412
    Abstract: A device for converting cellulose to sugar has a reaction chamber with a plurality of control components, and a control assembly. The control assembly is operatively connected to the reaction chamber, a drive assembly and control components to transmit and receive interoperability signals. The device has an inlet hopper with a detector, a crusher, an outlet hopper, a sensor assembly, a steam inlet, and a carbon dioxide inlet. The inlet hopper is configured to receive and analyze proportion data of matters in a feedstock and catalyst mixture via the detector. The crusher receives and grinds the mixture from the inlet hopper to induce chemical reaction for producing sugar. The outlet hopper is configured to determine a proportion data of matter in the grinded mixture. The control assembly is configured to determine adjustments need to be performed on the components and drive assembly to optimize the sugar production.
    Type: Application
    Filed: March 31, 2021
    Publication date: July 15, 2021
    Inventors: Benjamin Slager, Peter Cohen
  • System to convert cellulosic materials into sugar and method of using the same
    Patent number: 10994255
    Abstract: A device for converting cellulose to sugar comprises a reactor chamber with a plurality of control components, and a control assembly. The control assembly is operatively connected to the reactor chamber, a drive assembly and control components to transmit and receive interoperability signals. The device has an inlet hopper with a detector, a crusher, an outlet hopper, a sensor assembly, a steam inlet, and a carbon dioxide inlet. The inlet hopper is configured to receive and analyze proportion data of matters in a feedstock and catalyst mixture via the detector. The crusher receives and grinds the mixture from the inlet hopper to induce chemical reaction for producing sugar. The outlet hopper is configured to determine a proportion data of matter in the grinded mixture. The control assembly is configured to determine adjustments need to be performed on the components and drive assembly to optimize the sugar production.
    Type: Grant
    Filed: January 16, 2019
    Date of Patent: May 4, 2021
    Assignee: Alliance Bioenergy Plus Inc.
    Inventors: Benjamin Slager, Peter Cohen
  • SYSTEM TO CONVERT CELLULOSIC MATERIALS INTO SUGAR AND METHOD OF USING THE SAME
    Publication number: 20210001301
    Abstract: A device for converting cellulose to sugar comprises a reactor chamber with a plurality of control components, and a control assembly. The control assembly is operatively connected to the reactor chamber, a chive assembly and control components to transmit and receive interoperability signals. The device has an inlet hopper with a detector, a crusher, an outlet hopper, a sensor assembly, a steam inlet, and a carbon dioxide inlet. The inlet hopper is configured to receive and analyze proportion data of matters in a feedstock and catalyst mixture via the detector. The crusher receives and grinds the mixture from the inlet hopper to induce chemical reaction for producing sugar. The outlet hopper is configured to determine a proportion data of matter in the grinded mixture. The control assembly is configured to determine adjustments need to be performed on the components and chive assembly to optimize the sugar production.
    Type: Application
    Filed: January 16, 2019
    Publication date: January 7, 2021
    Inventors: Benjamin Slager, Peter Cohen
  • METHODS AND MATERIALS FOR EXPANDING ANTIGEN-SPECIFIC T CELLS IN CULTURE
    Publication number: 20200248140
    Abstract: This document provides methods and materials for expanding antigen-specific T cells (e.g., antigen-specific CD4+ T cells and/or antigen-specific CD8+ T cells) in culture. For example, methods and materials for performing a polyclonal stimulation step for a particular duration (e.g., from about 1 hour to about 48 hours) to increase the expansion of T cells having a desired antigen specificity are provided.
    Type: Application
    Filed: April 14, 2020
    Publication date: August 6, 2020
    Inventors: Peter A. Cohen, Sandra J. Gendler, Latha B. Pathangey, Dustin B. McCurry, Jessica E. Gorman, Mary L. Disis
  • Methods and materials for expanding antigen-specific T cells in culture
    Patent number: 10647961
    Abstract: This document provides methods and materials for expanding antigen-specific T cells (e.g., antigen-specific CD4+ T cells and/or antigen-specific CD8+ T cells) in culture. For example, methods and materials for performing a polyclonal stimulation step for a particular duration (e.g., from about 1 hour to about 48 hours) to increase the expansion of T cells having a desired antigen specificity are provided.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: May 12, 2020
    Assignees: Mayo Foundation for Medical Education and Research, University of Washington
    Inventors: Peter A. Cohen, Sandra J. Gendler, Latha B. Pathangey, Dustin B. McCurry, Jessica E. Gorman, Mary L. Disis
  • NETWORK COMPUTER SYSTEM TO IMPLEMENT ADDITIVE SERVICE VALUES FOR SERVICE PROVIDERS
    Publication number: 20200005198
    Abstract: A network computer system operates to monitor a plurality of requester devices to detect activities of requesters, and activities of transportation providers. Based on the monitored activities, the system forecasts a number of requesters that may be present in each of multiple subregions of a given geographic region, during an upcoming time interval. The system further estimates a target number of transportation providers to have available for requesters in each of the subregions. The system determines a supplemental value set for crediting transportation providers, in connection with each individual transport provider performing one or more activities that make the transport provider available to one or more of the multiple subregions during the upcoming time interval.
    Type: Application
    Filed: May 22, 2019
    Publication date: January 2, 2020
    Inventors: Hamid Nazerzadeh, Carter Mundell, SHICONG MENG, Whitney Chu, Ken Chong, Qitang Wang, Parijat Mazaumdar, Connor Soltas, Calvin Li, Rei Chiang, Awaneesh Verma, Peter Cohen
  • METHODS AND VACCINES FOR INDUCING IMMUNE RESPONSES TO MULTIPLE DIFFERENT MHC MOLECULES
    Publication number: 20190000948
    Abstract: This document provides methods and materials relating to isolated polypeptides, polypeptide preparations, vaccine preparations (e.g., anti-cancer vaccine preparations), and methods for vaccinating mammals. For example, polypeptides (e.g., CMV, MUC1, HER2, Mesothelin (MESO), TRAG-3, or CALR polypeptides) having the ability to be processed into different polypeptides such that the processed polypeptides as a group are capable of being presented by different MHC molecules present in a particular mammalian population are provided.
    Type: Application
    Filed: December 2, 2016
    Publication date: January 3, 2019
    Inventors: Dustin B. McCurry, Peter A. Cohen, Latha B. Pathangey, Sandra J. Gendler, Mary L. Disis
  • Blocking IL-9 signaling in conjunction with chemotherapy to treat cancer
    Patent number: 10166292
    Abstract: This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, methods and materials for using inhibitors of IL-9 signaling (e.g., anti-IL9 antibody preparations) in conjunction with chemotherapy to treat cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) or to reduce the growth rate of cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) within a mammal are provided.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: January 1, 2019
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Dominique B. Hoelzinger, Sandra J. Gendler, Peter A. Cohen, Ana L. Dominguez, Shannon E. Smith, Joseph Lustgarten
  • METHODS AND MATERIALS FOR EXPANDING ANTIGEN-SPECIFIC T CELLS IN CULTURE
    Publication number: 20180245042
    Abstract: This document provides methods and materials for expanding antigen-specific T cells (e.g., antigen-specific CD4+ T cells and/or antigen-specific CD8+ T cells) in culture. For example, methods and materials for performing a polyclonal stimulation step for a particular duration (e.g., from about 1 hour to about 48 hours) to increase the expansion of T cells having a desired antigen specificity are provided.
    Type: Application
    Filed: August 12, 2016
    Publication date: August 30, 2018
    Inventors: Peter A. Cohen, Sandra J. Gendler, Latha B. Pathangey, Dustin B. McCurry, Jessica E. Gorman, Mary L. Disis
  • BLOCKING IL-9 SIGNALING IN CONJUNCTION WITH CHEMOTHERAPY TO TREAT CANCER
    Publication number: 20180153994
    Abstract: This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, methods and materials for using inhibitors of IL-9 signaling (e.g., anti-IL9 antibody preparations) in conjunction with chemotherapy to treat cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) or to reduce the growth rate of cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) within a mammal are provided.
    Type: Application
    Filed: October 30, 2017
    Publication date: June 7, 2018
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Dominique B. Hoelzinger, Sandra J. Gendler, Peter A. Cohen, Ana L. Dominguez, Shannon E. Smith, Joseph Lustgarten
  • Blocking IL-9 signaling in conjunction with chemotherapy to treat cancer
    Patent number: 9833512
    Abstract: This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid tumors). For example, methods and materials for using inhibitors of IL-9 signaling (e.g., anti-IL9 antibody preparations) in conjunction with chemotherapy to treat cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) or to reduce the growth rate of cancer (e.g., solid tumors such as breast cancer tumors or colon cancer tumors) within a mammal are provided.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: December 5, 2017
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Dominique B. Hoelzinger, Sandra J. Gendler, Peter A. Cohen, Ana L. Dominguez, Shannon E. Smith, Joseph Lustgarten